Cite
Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis.
MLA
Ma, Ze-Gang, et al. “Quantitative Assessment of the Association between Fibroblast Growth Factor 20 Rs1721100 C/G Polymorphism and the Risk of Sporadic Parkinson’s Diseases: A Meta-Analysis.” Neurological Sciences, vol. 36, no. 1, Jan. 2015, pp. 47–51. EBSCOhost, https://doi.org/10.1007/s10072-014-1884-4.
APA
Ma, Z.-G., Xu, J., & Liu, T.-W. (2015). Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson’s diseases: a meta-analysis. Neurological Sciences, 36(1), 47–51. https://doi.org/10.1007/s10072-014-1884-4
Chicago
Ma, Ze-Gang, Jian Xu, and Tian-Wei Liu. 2015. “Quantitative Assessment of the Association between Fibroblast Growth Factor 20 Rs1721100 C/G Polymorphism and the Risk of Sporadic Parkinson’s Diseases: A Meta-Analysis.” Neurological Sciences 36 (1): 47–51. doi:10.1007/s10072-014-1884-4.